Cerus Corporation (CERS)
USD 1.21
(-6.2%)
USD 1.21
(-6.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 59.79 Million USD | 106.39% |
| 2022 | 28.97 Million USD | -59.18% |
| 2021 | 70.98 Million USD | 25.72% |
| 2020 | 56.46 Million USD | -2.35% |
| 2019 | 57.82 Million USD | 162.66% |
| 2018 | 22.01 Million USD | -26.13% |
| 2017 | 29.79 Million USD | 139.51% |
| 2016 | 12.44 Million USD | -26.31% |
| 2015 | 16.88 Million USD | 71.02% |
| 2014 | 9.87 Million USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 2.89 Million USD | -38.34% |
| 2011 | 4.69 Million USD | 49.73% |
| 2010 | 3.13 Million USD | 20813.33% |
| 2009 | 15 Thousand USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 2000.00 USD | -93.75% |
| 2006 | 32 Thousand USD | -52.94% |
| 2005 | 68 Thousand USD | -98.49% |
| 2004 | 4.5 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 16 Thousand USD | -68.63% |
| 2001 | 51 Thousand USD | -39.29% |
| 2000 | 84 Thousand USD | -16.0% |
| 1999 | 100 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 64.84 Million USD | 0.02% |
| 2024 Q3 | 77.11 Million USD | 0.01% |
| 2024 Q1 | 64.82 Million USD | 8.41% |
| 2023 Q4 | 59.79 Million USD | -19.05% |
| 2023 FY | 59.79 Million USD | 106.39% |
| 2023 Q1 | 69.78 Million USD | 140.87% |
| 2023 Q3 | 73.87 Million USD | 6.61% |
| 2023 Q2 | 69.29 Million USD | -0.71% |
| 2022 Q4 | 28.97 Million USD | -32.71% |
| 2022 FY | 28.97 Million USD | -59.18% |
| 2022 Q2 | 57.28 Million USD | -19.94% |
| 2022 Q1 | 71.55 Million USD | 0.81% |
| 2022 Q3 | 43.06 Million USD | -24.83% |
| 2021 Q2 | 71 Million USD | -0.44% |
| 2021 Q3 | 70.75 Million USD | -0.35% |
| 2021 Q4 | 70.98 Million USD | 0.33% |
| 2021 FY | 70.98 Million USD | 25.72% |
| 2021 Q1 | 71.31 Million USD | 26.3% |
| 2020 Q4 | 56.46 Million USD | -0.61% |
| 2020 Q2 | 57.11 Million USD | -0.61% |
| 2020 Q1 | 57.46 Million USD | -0.62% |
| 2020 FY | 56.46 Million USD | -2.35% |
| 2020 Q3 | 56.8 Million USD | -0.53% |
| 2019 Q4 | 57.82 Million USD | -0.02% |
| 2019 FY | 57.82 Million USD | 162.66% |
| 2019 Q1 | 58.74 Million USD | 166.86% |
| 2019 Q3 | 57.82 Million USD | -0.38% |
| 2019 Q2 | 58.04 Million USD | -1.18% |
| 2018 Q3 | 24.13 Million USD | -8.09% |
| 2018 Q2 | 26.26 Million USD | -7.49% |
| 2018 Q1 | 28.38 Million USD | -4.74% |
| 2018 FY | 22.01 Million USD | -26.13% |
| 2018 Q4 | 22.01 Million USD | -8.8% |
| 2017 Q1 | 10.46 Million USD | -15.89% |
| 2017 FY | 29.79 Million USD | 139.51% |
| 2017 Q4 | 29.79 Million USD | 0.06% |
| 2017 Q3 | 29.78 Million USD | 149.96% |
| 2017 Q2 | 11.91 Million USD | 13.86% |
| 2016 Q2 | 13.72 Million USD | -10.29% |
| 2016 FY | 12.44 Million USD | -26.31% |
| 2016 Q3 | 14.38 Million USD | 4.78% |
| 2016 Q4 | 12.44 Million USD | -13.5% |
| 2016 Q1 | 15.3 Million USD | -9.37% |
| 2015 Q1 | 9.29 Million USD | -5.88% |
| 2015 Q4 | 16.88 Million USD | -8.28% |
| 2015 Q3 | 18.4 Million USD | 5.96% |
| 2015 Q2 | 17.37 Million USD | 86.95% |
| 2015 FY | 16.88 Million USD | 71.02% |
| 2014 Q1 | - USD | 100.0% |
| 2014 Q4 | 9.87 Million USD | 0.12% |
| 2014 FY | 9.87 Million USD | 0.0% |
| 2014 Q2 | 9.84 Million USD | 0.0% |
| 2014 Q3 | 9.86 Million USD | 0.12% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | -178 Thousand USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q1 | 2.48 Million USD | -14.19% |
| 2013 Q2 | - USD | -100.0% |
| 2012 FY | 2.89 Million USD | -38.34% |
| 2012 Q4 | 2.89 Million USD | -12.43% |
| 2012 Q3 | 3.3 Million USD | -11.03% |
| 2012 Q2 | 3.71 Million USD | -9.91% |
| 2012 Q1 | 4.12 Million USD | -12.16% |
| 2011 Q3 | 4.91 Million USD | 127.42% |
| 2011 Q4 | 4.69 Million USD | -4.34% |
| 2011 Q2 | 2.15 Million USD | -18.74% |
| 2011 Q1 | 2.65 Million USD | -15.3% |
| 2011 FY | 4.69 Million USD | 49.73% |
| 2010 FY | 3.13 Million USD | 20813.33% |
| 2010 Q3 | 3.59 Million USD | -11.07% |
| 2010 Q4 | 3.13 Million USD | -12.84% |
| 2010 Q2 | 4.04 Million USD | -9.36% |
| 2010 Q1 | 4.46 Million USD | 29666.67% |
| 2009 FY | 15 Thousand USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | 18 Thousand USD | 0.0% |
| 2009 Q4 | 15 Thousand USD | -16.67% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | -100.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | -100.0% |
| 2007 FY | 2000.00 USD | -93.75% |
| 2007 Q3 | 6000.00 USD | -64.71% |
| 2007 Q4 | 2000.00 USD | -66.67% |
| 2007 Q2 | 17 Thousand USD | -37.04% |
| 2007 Q1 | 27 Thousand USD | -15.63% |
| 2006 Q1 | 120 Thousand USD | 76.47% |
| 2006 Q2 | 65 Thousand USD | -45.83% |
| 2006 Q3 | 41 Thousand USD | -36.92% |
| 2006 Q4 | 32 Thousand USD | -21.95% |
| 2006 FY | 32 Thousand USD | -52.94% |
| 2005 Q4 | 68 Thousand USD | -98.56% |
| 2005 Q3 | 4.73 Million USD | 1.94% |
| 2005 FY | 68 Thousand USD | -98.49% |
| 2005 Q1 | 4.55 Million USD | 1.27% |
| 2005 Q2 | 4.64 Million USD | 1.95% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | 4.5 Million USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | 4.5 Million USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q3 | - USD | -100.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | 52.91 Million USD | 2.91% |
| 2003 Q1 | 51.42 Million USD | 321293.75% |
| 2002 Q3 | 25 Thousand USD | -26.47% |
| 2002 Q4 | 16 Thousand USD | -36.0% |
| 2002 Q1 | 45 Thousand USD | -11.76% |
| 2002 FY | 16 Thousand USD | -68.63% |
| 2002 Q2 | 34 Thousand USD | -24.44% |
| 2001 Q2 | 67 Thousand USD | -9.46% |
| 2001 Q4 | 51 Thousand USD | -13.56% |
| 2001 FY | 51 Thousand USD | -39.29% |
| 2001 Q3 | 59 Thousand USD | -11.94% |
| 2001 Q1 | 74 Thousand USD | -11.9% |
| 2000 Q4 | 84 Thousand USD | -3.45% |
| 2000 FY | 84 Thousand USD | -16.0% |
| 2000 Q1 | 106 Thousand USD | 6.0% |
| 2000 Q2 | 96 Thousand USD | -9.43% |
| 2000 Q3 | 87 Thousand USD | -9.38% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | 0.0% |
| 1999 Q4 | 100 Thousand USD | 0.0% |
| 1999 FY | 100 Thousand USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | -100.0% |
| 1998 Q2 | 8.3 Million USD | 0.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q1 | 100 Thousand USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -65.631% |
| BrainsWay Ltd. | 239 Thousand USD | -24919.247% |
| Envoy Medical, Inc. | 404 Thousand USD | -14700.99% |
| electroCore, Inc. | 537 Thousand USD | -11035.196% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -498200.0% |
| IceCure Medical Ltd | 376 Thousand USD | -15803.191% |
| Inogen, Inc. | 18.27 Million USD | -227.291% |
| OrthoPediatrics Corp. | 13.45 Million USD | -344.283% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -29948.241% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -16339.938% |
| MaxCyte, Inc. | 17.96 Million USD | -232.773% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -108061.493% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 35.777% |
| PAVmed Inc | 2.96 Million USD | -1920.135% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -862.279% |
| RxSight, Inc. | 1.21 Million USD | -4837.737% |
| Sight Sciences, Inc. | 31.7 Million USD | -88.583% |
| SI-BONE, Inc. | 36.06 Million USD | -65.801% |
| TELA Bio, Inc. | 40.51 Million USD | -47.59% |
| Treace Medical Concepts, Inc. | 53 Million USD | -12.806% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -3831.361% |
| Acutus Medical, Inc. | 32.65 Million USD | -83.12% |
| Talis Biomedical Corporation | 16.78 Million USD | -256.225% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -1378.269% |
| CVRx, Inc. | 30.38 Million USD | -96.814% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -5780.051% |
| Bioventus Inc. | 366.99 Million USD | 83.707% |
| Venus Concept Inc. | 70.79 Million USD | 15.53% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -4706.752% |
| LivaNova PLC | 568.54 Million USD | 89.483% |
| 908 Devices Inc. | 3.92 Million USD | -1421.914% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 88.299% |
| Nemaura Medical Inc. | 3.08 Million USD | -1836.618% |
| NeuroPace, Inc. | 56.95 Million USD | -4.99% |
| LENSAR, Inc. | 1.75 Million USD | -3316.914% |
| Apyx Medical Corporation | 33.18 Million USD | -80.19% |
| Cutera, Inc. | 418.69 Million USD | 85.718% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -297.474% |
| BioSig Technologies, Inc. | 103 Thousand USD | -57954.369% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -122.257% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -501.025% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 95.973% |
| Axonics, Inc. | 25.84 Million USD | -131.409% |
| Outset Medical, Inc. | 134.59 Million USD | 55.573% |
| IRIDEX Corporation | 1.75 Million USD | -3314.963% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | -16.473% |
| IRadimed Corporation | 1.61 Million USD | -3602.355% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -33875.0% |
| INVO Bioscience, Inc. | 6.77 Million USD | -782.456% |
| Telesis Bio, Inc. | 5.26 Million USD | -1034.864% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -901.391% |
| Varex Imaging Corporation | 464.2 Million USD | 87.118% |
| Quipt Home Medical Corp. | 60.82 Million USD | 1.685% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -10069.388% |
| Pulmonx Corporation | 35.08 Million USD | -70.412% |
| Dynatronics Corporation | 3.25 Million USD | -1735.09% |
| Modular Medical, Inc. | 817 Thousand USD | -7218.972% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -39500.0% |
| Semler Scientific, Inc. | 70 Thousand USD | -85322.857% |
| InMode Ltd. | 6.61 Million USD | -804.219% |
| Bruker Corporation | 1.14 Billion USD | 94.775% |
| Cytosorbents Corporation | 2.54 Million USD | -2251.528% |
| DexCom, Inc. | 2.57 Billion USD | 97.676% |
| Align Technology, Inc. | 96.96 Million USD | 38.334% |
| Viveve Medical, Inc. | 5.12 Million USD | -1066.979% |
| ZimVie Inc. | 508.79 Million USD | 88.248% |
| Movano Inc. | 15.00 USD | -398639900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -229.909% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 84.999% |
| Profound Medical Corp. | 4.97 Million USD | -1102.07% |
| Insulet Corporation | 1.36 Billion USD | 95.624% |
| enVVeno Medical Corporation | 1.06 Million USD | -5519.925% |
| Surmodics, Inc. | 29.4 Million USD | -103.353% |
| iCAD, Inc. | 273 Thousand USD | -21803.297% |
| Nuwellis, Inc. | 221 Thousand USD | -26957.014% |
| Biotricity, Inc. | 10.85 Million USD | -450.819% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -71.09% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -9102.91% |
| InspireMD, Inc. | 1.03 Million USD | -5660.694% |
| PAVmed Inc. | 2.96 Million USD | -1920.135% |
| BIOLASE, Inc. | 13.98 Million USD | -327.572% |
| Beyond Air, Inc. | 14.72 Million USD | -306.195% |
| FONAR Corporation | 37.92 Million USD | -57.651% |
| AxoGen, Inc. | 46.6 Million USD | -28.309% |
| Vivani Medical, Inc. | 19.31 Million USD | -209.615% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -34.036% |
| Inari Medical, Inc. | 30.35 Million USD | -96.989% |
| UFP Technologies, Inc. | 28 Million USD | -113.557% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -13676.452% |
| Tenon Medical, Inc. | 428 Thousand USD | -13871.028% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -5867.665% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -2678.392% |
| AdaptHealth Corp. | 2.09 Billion USD | 97.145% |
| Sintx Technologies, Inc. | 3.68 Million USD | -1521.806% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -60.643% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -10069.388% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -9932.886% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 93.298% |
| TransMedics Group, Inc. | 506.2 Million USD | 88.187% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -9751.071% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -64554.809% |
| Hyperfine, Inc. | 64 Thousand USD | -93331.25% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 68.318% |
| Biomerica, Inc. | 459 Thousand USD | -12927.451% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -13203.284% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -31373.732% |
| Silk Road Medical, Inc | 75.62 Million USD | 20.932% |